The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study.

Autor: Gameil, Mohammed Ali1 (AUTHOR) dr_maligameil79@mans.edu.eg, Yousef, Elshahat Ali Ahmed Mohamed2 (AUTHOR) Drshahat@mans.edu.eg, Marzouk, Rehab Elsayed3 (AUTHOR) dr_rehabmm85@yahoo.com, Emara, Mohamed H.4,5 (AUTHOR) Emara_20007@yahoo.com, Abdelkader, Abeer H.6 (AUTHOR) abeeralashry0@gmail.com, Salama, Rasha Ibrahim6 (AUTHOR) rashasalama1010@gmail.com
Zdroj: Diabetology & Metabolic Syndrome. 12/4/2024, Vol. 16 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje